OBJECTIVE
To evaluate the efficacy and side effects of oral pilocarpine for the treatment of ocular symptoms in patients with primary Sjögren's syndrome (SS).
METHODS
A 12 week, single centre, randomised controlled study was performed. Twenty nine patients were randomly assigned to receive oral